Reported Sep 5, 2018 · Terminated

Valsartan Tablets, USP 320 mg Rx Only 30 Tablets (6x5) Unit Dose NDC 50268-786-13 Manufactured for: AvKARE, Inc.…

AVKARE Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: AVKARE Inc. · 615 N 1st St · Pulaski, TN · 38478-2403

Is this the product you have?

  • Valsartan Tablets, USP 320 mg Rx Only 30 Tablets (6x5) Unit
  • Dose NDC 50268-786-13 Manufactured forAvKARE, Inc. Pulaski, TN 38478
Lot codes and dates
  • Lots
    • 17718 Exp. 07/2018
    • 18700 Exp. 01/2019
    • 19133 Exp. 02/2019
    • 19532 Exp. 04/2019
Amount recalled
1496 cartons (44,880 tablets)

This recall covers 4 products

The agency filed one notice per product. You are reading one of them; the other 3 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new AVKARE Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated May 7, 2020 · Data as of Sep 19, 5:53 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.